JANENE EBAUGH: Open Payments
NPI 1619307766 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 22 payments from 13 companies in 2025. Trend: 2023 $15 · 2024 $36 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Novo Nordisk Inc | 3 | $64 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Lilly USA, LLC | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: FARXIGA, Wegovy, JARDIANCE, XIFAXAN, AIRSUPRA, Flexitouch Plus, The Cologuard Plus Collection Kit, VOQUEZNA.
Industry payments across DE — which companies pay providers there.
